Spherical Crystallization of Mebendazole to Improve Processability

REFERENCES

• HG Brittain, SR Vippagunta, and DJW Grant. (2001). Crystalline solids. Adv. Drug Del. Rev. 48:3–26.
   PubMed Web of Science ®Google Scholar
• S Byrn, R Pfeiffer, M Ganey, C Hoiberg, and G Poochikian. (1995). Pharmaceutical solids: a strategic approach to regulatory considerations. Pharm. Res. 12 (7):945–954.
   PubMed Web of Science ®Google Scholar
• D Singhal, and W Curatolo. (2004). Drug polymorphism and dosage form design: a practical perspective. Adv. Drug Del. Rev. 56 (3):335–347.
   PubMed Web of Science ®Google Scholar
• S Banga, G Chawla, D Varandani, BR Mehta, and AK Bansal. (2007). Modification of crystal habit of celecoxib for improved processability. J. Pharm. Pharmacol. 59 (1):29–39.
   PubMed Web of Science ®Google Scholar
• AK Tiwary. (2001). Modification of crystal habit and its role in dosage form performance. Drug Develop. Ind. Pharm. 27 (7):699–709.
   Google Scholar
• D Simmons, R Ranz, N Gyanchandani, and D Picotte. (1972). Polymorphism in pharmaceuticals ii tolbutamide. Can. J. Pharm.Sci. 7 (4):121–123.
   Web of Science ®Google Scholar
• PD Martino, AMG Hermann, P Conflant, M Drache, and JC Guyot. (1996). A new pure paracetamol for direct compression: The orthorhombic form. Int. J. Pharm. 128 (1–2):1–8.
   Google Scholar
• DA Gonzalez, and B Biscans. (2002). Spherical agglomeration during crystallization of an active pharmaceutical ingredient. Powder Technol. 128 (2–3):188–194.
   Web of Science ®Google Scholar
• A Ribardiere, P Tchoreloff, G Couarraz, and F Puisieux. (1996). Modification of ketoprofen bead structure produced by the spherical crystallization technique with a two-solvent system. Int. J. Pharm. 144 (2):195–207.
   Google Scholar
• AR Paradkar, AP Pawar, KH Mahadik, and SS Kadam. (1993). Spherical crystallization: A novel particle design technique. Indian Drugs. 31 (6):229–233.
   Google Scholar
• PS Revesz, MH Nezdei, B Farkas, H Goezo, KP Hodi, and I Eros. (2002). Crystal growth of drug materials by spherical crystallization. J Crystal Growth. 237–239 (3):2240–2245.
   Google Scholar
• Y Kawashima, M Okumura, and H Takenaka. (1982). Spherical crystallization: Direct spherical agglomeration of salicylic acid crystals during crystallization. Science. 216:1127–1128.
   PubMed Web of Science ®Google Scholar
• MS Gordon, and ZT Chowhan. (1990). Manipulation of naproxen particle morphology via the spherical crystallization technique to achieve a directly compressible raw material. Drug Develop. Ind. Pharm. 16 (8):1279–1290.
   Web of Science ®Google Scholar
• AR Paradkar, AP Pawar, JK Chordiya, VB Patil, and AR Ketkar. (2002). Spherical crystallization of celecoxib. Drug Develop. Ind. Pharm. 28 (10):1213–1220.
   PubMed Web of Science ®Google Scholar
• K Kachrimanis, G Ktistis, and S Malamataris. (1998). Crystallization conditions and physicomechanical properties of Ibuprofen-Eudragit S100 spherical crystal agglomerates prepared by the solvent-change technique. Int. J. Pharm. 173 (1–2):61–74.
   Google Scholar
• CL Viswanathan, K.Kulkarni S, and DR Kolwankar. (2006). Spherical agglomeration of mefenamic acid and nabumetone to improve micromeretics and solubility. AAPS Pharm. Sci. Tech. 7 (2):E1–4.
   Web of Science ®Google Scholar
• K Kachrimanis, G Ktistis, S Malamataris. Mebendazole drug profile, Wikipedia online encyclopedia. en.wikipedia.org/wiki.wikipedia. Accessed on 24.07.06.
   Google Scholar
• E Swanepoel, W Liebenberg, B Devarakonda, and MMD Villiers. (2003). Developing a discriminatory dissolution test for three mebendazole polymorphs based on solubility differences. Pharmazie. 58 (2):117–121.
   PubMed Web of Science ®Google Scholar
• S Bhadra, M Kumar, S Jain, S Agrawal, and GP Agrawal. (2004). Spherical crystallization of mefenamic acid. Pharm. Tech. 28 (2):66–76.
   Google Scholar
• G Brittain. (2001). Particle size distribution. Part 1. Representations of particle shape, size, and distribution. Pharm. Tech. 38–45.
   Google Scholar
• USP, and Bulk Density and Tapped Density. United States Pharmacopoeia, RockvilleMD, (2006) 2638–2639.
   Google Scholar
• JK Guillory. Generation of polymorphs, hydrates, solvates and amorphous solidsPolymorphism in pharmaceutical solidsHG Brittain. Marcel Dekker, New York, (1999) 183–226.
   Google Scholar
• AJ Mackellar, JM Newton, BZ Chowdhary, and CA Orr. (1994). The controlled crystallization of a model powder: 1.The effects of altering the stirring rate and the supersaturation profile, and the incorporation of a surfactant (poloxamer 188). Int. J. Pharm. 112 (1):65–78.
   Google Scholar
• V Rudolph, Q Li, B Weigl, and A Earl. (2004). Interparticle vander waals force in powder fowability and compactibility. Int. J. Pharm. 280 (1–2):77–93.
   PubMed Web of Science ®Google Scholar
• JI Wells. Powder flow propertiesPharmaceutical Preformulation; Physicochemical Properties of Drug SubstancesJI Wells. Ellis Horwood Ltd, UK, (1988) 209–214.
   Google Scholar
• AK Tiwary, and GM Panpali. (1999). Influence of crystal habit on trimethoprim suspension formulation. Pharm. Res. 16:261–265.
   PubMed Web of Science ®Google Scholar
• N Rasenack, and BW Muller. (2002). Crystal habit and tableting behaviour. Int. J. Pharm. 244:45–57.
   PubMed Web of Science ®Google Scholar
• HA Garekani, JL Ford, MH Rubinstein, and AR Siaahboomi. (2001). Effect of compression force, compression speed, and particle size on the compression properties of paracetamol. Drug Develop. Ind.Pharm. 27 (9):935–942.
   PubMed Web of Science ®Google Scholar
• R Bandopadhyay, and DJW Grant. (2002). Plasticity and slip system of plate-shaped crystals of l-lysine monohydrochloride dihydrate. Pharm. Res. 19 (4):491–496.
   PubMed Web of Science ®Google Scholar
• G Chawla, and AK Bansal. (2004). Effect of processing on celecoxib and its solvates. Pharm. Develop. Technol. 9 (4):419–433.
   PubMed Web of Science ®Google Scholar
• W Jetzer, H Leuenberger, and H Sucker. The compressibilty and compactibilty of pharmaceutical powders. Pharm. Tech. 1983:33–39.
   Google Scholar
• KP Rao, G Chawla, AM Kaushal, and AK Bansal. (2005). Impact of solid-state properties on lubrication efficacy of magnesium stearate. Pharm. Develop. Technol. 10 (3):423–437.
   PubMed Web of Science ®Google Scholar
• HA Garekani, JL Ford, MH Rubinstein, and AR Siaahboomi. (2000). Highly compressible paracetamol – ii. Compression properties. Int. J. Pharm.. 208 (1–2):101–110.
   Google Scholar
• Guidance for Industry, Dissolution Testing of Immediate Release Solid Oral Dosage Forms, and US Rockville. Food and Drug Administration, MDUSA, (1997) .
   Google Scholar